Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Acquisitions & Divestments (2023 - 2024)

Historic Change in Acquisitions & Divestments for Oncology Institute (TOI) over the last 2 years, with Q3 2024 value amounting to $10.0 million.

  • Oncology Institute's Change in Acquisitions & Divestments rose 1661.81% to $10.0 million in Q3 2024 from the same period last year, while for Jun 2025 it was $10.0 million, marking a year-over-year decrease of 8364.17%. This contributed to the annual value of $50.0 million for FY2024, which is 3846.76% down from last year.
  • Oncology Institute's Change in Acquisitions & Divestments amounted to $10.0 million in Q3 2024, which was up 1661.81% from $20.0 million recorded in Q2 2024.
  • Over the past 5 years, Oncology Institute's Change in Acquisitions & Divestments peaked at $30.1 million during Q2 2023, and registered a low of $8.6 million during Q3 2023.